Epigral · NSE: EPIGRAL · BSE: 543332

Q3 FY23 results · Oct–Dec 2022

Epigral reported revenue from operations of ₹537.84 crore (up 27.4% from Q3 FY22) and net profit of ₹77.20 crore (up 10.7% from Q3 FY22) for Q3 FY23 (Oct–Dec 2022), on a consolidated basis.

Consolidated · ₹ crore
ItemQ3 FY23Q3 FY22YoYQ2 FY23QoQ
Revenue from operations537.84422.17+27.4%555.53−3.2%
Other income(0.26)(0.30)Loss narrowed1.68Turned loss
Total income537.58421.88+27.4%557.21−3.5%
Profit before tax114.40108.90+5.0%141.66−19.2%
Net profit for the period77.2069.73+10.7%91.57−15.7%
EPS, basic (₹)18.5816.78+10.7%22.04−15.7%
Net margin (%)14.416.516.5
Standalone · ₹ crore
ItemQ3 FY23Q3 FY22YoYQ2 FY23QoQ
Revenue from operations537.84422.17+27.4%555.53−3.2%
Other income(0.26)(0.30)Loss narrowed1.68Turned loss
Total income537.58421.88+27.4%557.21−3.5%
Profit before tax114.40108.90+5.0%141.66−19.2%
Net profit for the period77.2069.73+10.7%91.57−15.7%
EPS, basic (₹)18.5816.78+10.7%22.04−15.7%
Net margin (%)14.416.516.5
Consolidated
Filed with BSE
19 Jan 2023, 17:26 IST
Board meeting
19 Jan 2023
Period
01 Oct 2022 to 31 Dec 2022
Review status
Unaudited
Source
XBRL filing on BSE
Standalone
Filed with BSE
19 Jan 2023, 17:26 IST
Board meeting
19 Jan 2023
Period
01 Oct 2022 to 31 Dec 2022
Review status
Unaudited
Source
XBRL filing on BSE